全文获取类型
收费全文 | 5629篇 |
免费 | 269篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 192篇 |
妇产科学 | 185篇 |
基础医学 | 803篇 |
口腔科学 | 64篇 |
临床医学 | 371篇 |
内科学 | 1458篇 |
皮肤病学 | 69篇 |
神经病学 | 726篇 |
特种医学 | 249篇 |
外国民族医学 | 10篇 |
外科学 | 531篇 |
综合类 | 15篇 |
预防医学 | 225篇 |
眼科学 | 44篇 |
药学 | 312篇 |
中国医学 | 13篇 |
肿瘤学 | 639篇 |
出版年
2024年 | 13篇 |
2023年 | 37篇 |
2022年 | 81篇 |
2021年 | 145篇 |
2020年 | 89篇 |
2019年 | 93篇 |
2018年 | 147篇 |
2017年 | 100篇 |
2016年 | 113篇 |
2015年 | 151篇 |
2014年 | 175篇 |
2013年 | 243篇 |
2012年 | 365篇 |
2011年 | 373篇 |
2010年 | 205篇 |
2009年 | 217篇 |
2008年 | 343篇 |
2007年 | 336篇 |
2006年 | 357篇 |
2005年 | 298篇 |
2004年 | 296篇 |
2003年 | 257篇 |
2002年 | 245篇 |
2001年 | 115篇 |
2000年 | 112篇 |
1999年 | 119篇 |
1998年 | 68篇 |
1997年 | 48篇 |
1996年 | 47篇 |
1995年 | 34篇 |
1994年 | 37篇 |
1993年 | 30篇 |
1992年 | 76篇 |
1991年 | 53篇 |
1990年 | 67篇 |
1989年 | 45篇 |
1988年 | 47篇 |
1987年 | 45篇 |
1986年 | 36篇 |
1985年 | 31篇 |
1984年 | 34篇 |
1983年 | 18篇 |
1981年 | 13篇 |
1980年 | 13篇 |
1979年 | 22篇 |
1978年 | 12篇 |
1977年 | 13篇 |
1976年 | 15篇 |
1975年 | 16篇 |
1972年 | 13篇 |
排序方式: 共有5929条查询结果,搜索用时 0 毫秒
61.
G. Bigatti N. Segers W. Boeckx L. Gruft A. Mariani I. Brosens 《Gynecological surgery》2006,3(3):175-179
This study was designed to test the effect of recombinant tissue-type plasminogen activator (rt-PA) in reducing adhesion formation and to observe its influence on peritoneal neoangiogenesis. In 20 Wistar rats, a 4-cm midline incision was made, and a square piece of Silastic, 0.5×0.5 cm and 0.2 mm thick, was fixed on the right side of the peritoneum with two separate angular stitches of nylon 9/O. The rats were randomized into two groups of 10 animals each. In the first group we injected 0.2 mg of rt-PA intraperitoneally three times a day. The second group of 10 rats was used as a control group. Each rat was reoperated on day 12. Intraperitoneal injection of rt-PA seemed not to affect adhesion formation, as a 100% adhesion rate was reported in the treated group compared with 90% of the control group. The results showed that rt-PA acts on the neoangiogenesis involved in postsurgical adhesion formation by reducing the size and length of the vessels. This action seems to slow down peritoneal healing with a negative effect on postsurgical adhesion prevention. 相似文献
62.
D Rubello A Piotto F Medi M D Gross B Shapiro P Erba G Mariani M R Pelizzo 《European journal of surgical oncology》2005,31(2):191-196
AIM: In this study, we evaluated the efficacy of low dose (99m)Tc-Sestamibi administration for radioguided parathyroid surgery in patients with primary hyperparathyroidism (PHPT). METHODS: Three hundred consecutive PHPT patients were studied between September, 1999 and July, 2003. Pre-operative work-up included (99m)Tc-pertechnetate/(99m)Tc-Sestamibi subtraction scintigraphy and high resolution ultrasonography (US). 37MBq of (99m)Tc-Sestamibi was injected i.v. in the operating suite approximately 10 min prior to the beginning of the surgical procedure for intraoperative radiolocalization; quick parathyroid hormone (QPTH) assays were performed. RESULTS: Two hundred and seven of the 211 patients selected for minimally-invasive radioguided parathyroidectomy (MIRP) were successfully treated for a solitary parathyroid adenoma (PA) through a 2-2.5 cm skin incision (mean operative time 35 min, mean hospital stay 1.2 days). In the 89 patients selected for traditional bilateral neck exploration (BNE), radioguided surgery was not as successful in the identification of the PA, especially in patients with (99m)Tc-Sestamibi-avid thyroid nodules. Nevertheless, the combination of probe and QPTH measurement was very helpful in patients with multigland disease. CONCLUSIONS: Low-dose (99m)Tc-Sestamibi administered few minutes before surgery is sufficient for MIRP in patients with high likelihood of a solitary PA and without concomitant (99m)Tc-Sestamibi-avid thyroid nodules. The combination of radioguided surgery and QPTH measurements is very useful in the early identification of unanticipated multigland disease. 相似文献
63.
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma. 总被引:3,自引:0,他引:3
S Mariani M Muraro F Pantaleoni F Fiore B Nuschak S Peola M Foglietta A Palumbo M Coscia B Castella B Bruno R Bertieri L Boano M Boccadoro M Massaia 《Leukemia》2005,19(4):664-670
The aim of this study was to investigate the in vitro immunomodulatory effects of zoledronic acid (Zol) on peripheral blood Vgamma9/Vdelta2 (gammadelta) T cells of normal donors and multiple myeloma (MM) patients. gammadelta T cells were stimulated with Zol and low doses of interleukin-2 (IL-2), and then analyzed for proliferation, cytokine production, and generation of effector activity against myeloma cell lines and primary myeloma cells. Proliferation of gammadelta T cells was observed in 100% of normal donors and 50% of MM patients. gammadelta T cells produced IFN-gamma, surface mobilized the CD107a and CD107b antigens, and exerted direct cell-to-cell antimyeloma activity irrespective of the ability to proliferate to Zol and IL-2. The memory phenotype was predominant in the MM gammadelta T cells that proliferated in response to Zol (responders), whereas effector cells were predominant in those that did not (nonresponders). Zol induced antimyeloma activity through the monocyte-dependent activation of gammadelta T cells and by enhancing the immunosensitivity of myeloma cells to gammadelta T cells. Mevastatin, a specific inhibitor of hydroxy-methylglutaryl-CoA reductase, completely abrogated this antimyeloma activity. 相似文献
64.
Cucina A Sapienza P Corvino V Borrelli V Mariani V Randone B Santoro D'Angelo L Cavallaro A 《Surgery》2000,127(3):316-322
BACKGROUND: Cigarette smoking influences and enhances the development of atherosclerosis. We investigated if nicotine, an important constituent of cigarette smoking, has a stimulatory effect on bovine smooth muscle cell proliferation in vitro through the mediation of bFGF and TGF-beta 1. METHODS: Bovine aortic smooth muscle cells (SMC) were stimulated with (-)-nicotine at various concentrations ranging from 6 x 10(-4) mol/L to 6 x 10(-8) mol/L. SMC viability and count were assessed. The presence of bFGF and TGF-beta 1 in serum-free conditioned media was determined by the inhibition antibody-binding assay, and the mitogenic activity of (-)-nicotine on SMC was analyzed by the 3H-thymidine uptake. Polymerase chain reaction was used to study the expression of bFGF and TGF-beta 1. RESULTS: The bFGF release after (-)-nicotine stimulation was greater than in the controls, whereas TGF-beta 1 release was lower. The greatest mitogenic activity was found at a (-)-nicotine concentration of 6 x 10(-6) mol/L. The addition of monoclonal antibody anti-bFGF decreased the 3H-thymidine uptake of SMC exposed to (-)-nicotine, whereas the addition of monoclonal antibody anti-TGF-beta 1 increased the 3H-thymidine uptake of stimulated SMC. bFGF mRNA expression was significantly higher in SMC exposed to (-)-nicotine than in the controls, but TGF-beta 1 mRNA expression was significantly lower in SMC exposed to 6 x 10(-6) mol/L (-)-nicotine than in SMC treated with the other concentrations of (-)-nicotine and in controls. CONCLUSIONS: Nicotine is a potent regulator of bFGF and TGF-beta 1 production and release by aortic SMC, and it seems to play an important role in the development and progression of atherosclerosis and neointimal fibrous hyperplasia. 相似文献
65.
Pugliese R Maggioni D Berardi V Scandroglio I Pisani D Mariani A Di Lernia S Valli C Cocotta E 《International surgery》2000,85(3):209-215
The extent of lymph node dissection in stomach adenocarcinoma is currently under debate. Japanese data strongly support the therapeutic value of extended lymphadenectomy (D2 node dissection), whereas in Western countries several prospective trials have recently been completed with contrasting results. During the period May 1993 to May 1998, 164 patients with gastric cancer were observed: 136 patients, treated with a radical surgical procedure including lymph node dissection according to the guidelines of the Japanese Research Society for Gastric Cancer, were eligible for our analysis. Clinical, histopathological, and surgical factors were examined for their influence on long-term survival. Our results on morbidity and mortality rates are similar to Japanese series: we suggest that the experience and training of the surgeon and his personal attitude towards extensive lymph node dissection may, therefore, be a major factor influencing the morbidity associated with the procedure. The relatively high estimated 3-year survival rate (52%) suggests support for extended lymphadenectomy (D2 dissection) in gastric cancer as standard treatment. 相似文献
66.
67.
Cyclosporin A in the ocular fluids of uveitis patients following long-term systemic administration 总被引:1,自引:0,他引:1
Paolo Mora Uta Ceglarek Francesca Manzotti Laura Zavota Arturo Carta Raffaella Aldigeri Jelka G. Orsoni 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2008,246(7):1047-1052
BACKGROUND/AIMS: To determine the levels of cyclosporin A (CsA) in tears and the anterior segment of the eye following long-term oral intake for autoimmune diseases. METHODS: Subjects taking oral CsA to treat relapsing autoimmune ocular inflammation were included in this study. All of the patients had been quiescent for at least 6 months. In patients scheduled for cataract extraction (group A), the CsA levels in the blood, aqueous humour and anterior capsule of the lens were determined. In subjects not requiring surgical intervention (group B), CsA was measured in tears and blood. The samples were analysed using turbulent flow chromatography coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS). RESULTS: There were 19 subjects in group A and 43 subjects in group B. CsA was detectable in all of the tear samples with a mean value of 22.4 +/- 20.2 ng/ml and there was a significant positive correlation between the CsA levels in tears and blood (P = 0.012). CsA was not detected in any of the surgical samples. CONCLUSION: LC-MS/MS proved very sensitive for detecting CsA in low-volume biological samples. CsA was present in human tears in proportion to the blood level after an average of 12 hours from the last oral intake. 相似文献
68.
Stephanie T.Kuwahara Shuwan Liu Andrew Chareunsouk Maxwell Serowoky Francesca V.Mariani 《骨研究(英文版)》2022,(1):20-30
Uncovering the molecular pathways that drive skeletal repair has been an ongoing challenge. Initial efforts have relied on in vitro assays to identify the key signaling pathways that drive cartilage and bone differentiation. While these assays can provide some clues, assessing specific pathways in animal models is critical. Furthermore, definitive proof that a pathway is required for skeletal repair is best provided using genetic tests. Stimulating the Hh(Hedgehog) pathway can promote cartilage ... 相似文献
69.
HPV circulating tumor DNA to monitor the efficacy of anti‐PD‐1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report 下载免费PDF全文
Luc Cabel François‐Clément Bidard Vincent Servois Wulfran Cacheux Pascale Mariani Emanuela Romano Mathieu Minsat Ivan Bieche Fereshteh Farkhondeh Emmanuelle Jeannot Bruno Buecher 《International journal of cancer. Journal international du cancer》2017,141(8):1667-1670
Squamous cell carcinoma of the anal canal (SCCA) is a rare HPV‐associated cancer with limited sensitivity to standard chemotherapy. In a phase 2 study, nivolumab, an anti PD‐1 immune checkpoint inhibitor, demonstrated significant efficacy as single‐agent therapy in metastatic SCCA patients. Nevertheless, imaging assessment by standard RECIST criteria of the efficacy of immune therapy can be difficult in some patients due to tumor immune cell infiltration, and biomarkers of treatment efficacy are needed. We have previously developed a quantitative droplet digital PCR (ddPCR) technique to detect HPV circulating tumor DNA (HPV ctDNA), with excellent sensitivity and specificity. Here, we report, for the first time, the kinetics of HPV ctDNA during therapy in a patient with metastatic SCCA, who obtained sustained partial response to single‐agent nivolumab. We observed an early and very significant decrease of HPV ctDNA during therapy from the baseline level of 3713 copies/ml plasma to 564 copies/ml plasma at 4 weeks, and 156 copies/ml at 6 weeks, followed by a plateau. This observation provides proof‐of‐concept that HPV ctDNA can be used as a noninvasive early dynamic biomarker to monitor the efficacy of new immunotherapy agents. 相似文献
70.
Targeting of the tumor stroma, including the tumor vasculature, represents a new frontier in the treatment of malignancy.
Preclinical studies and clinical experiences have established that stroma-directed novel agents must be combined with conventional
therapies in order to achieve relevant therapeutic efficacy. Here we review our preclinical experience on combinations of
paclitaxel with a tyrosine kinase receptor inhibitor of angiogenesis (SU6668) and a vascular disrupting agent (VDA, ZD6126),
and discuss the critical factors that determine the outcome of these treatments. We also analyze the relevance of the intrinsic
sensitivity of the tumor to the drugs, as well as the possibility that the two combined agents synergistically affect the
vasculature or independently target the host and the tumor compartments. Finally, we discuss the need to carefully optimize
scheduling and sequencing, through the use of reliable end points, in order to avoid negative pharmacological interactions
and to improve the antineoplastic efficacy of paclitaxel-based combination treatments. 相似文献